Structured Review
Pbpk, supplied by Simcyp, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simcyp+v21/pbpk/pmc13136160-12-3-4
Average 86 stars, based on 1 article reviews
Images
Related Articles
Biomarker Discovery:Article Title: Pharmacometric modeling of opioid disposition in pregnancy: a systematic review of PopPK and PBPK approaches, model limitations, and future directions Article Snippet: Buprenorphine , , PBPK (Simcyp v15.1) , AUC, Cavg, Cmax: within ±25% of observed means except Cavg in T3 (−26.3%) , Sublingual route implementation poorly documented → reproducibility concerns; underpredicted clearance in T2/T3 suggesting need to better characterize CYP3A4/UGT induction , , , , Pregnancy substantially reduces buprenorphine systemic exposure (∼50% in T3) due to increased hepatic clearance and volume of distribution, suggesting clinical need for increased dosing frequency. .. Buprenorphine , , Article Title: Pharmacometric modeling of opioid disposition in pregnancy: a systematic review of PopPK and PBPK approaches, model limitations, and future directions Article Snippet: .. Codeine/Morphine , , Formulation:Article Title: Physiologically‐based pharmacokinetic modelling of a CYP2C19 substrate, BMS‐823778, utilizing pharmacogenetic data Article Snippet: .. The blood/plasma partition ratio was determined to be 0.8. table ft1 table-wrap mode="anchored" t5 Table 2 caption a7 Parameters Values Parameters Values MW (g mol –1 ) 328 CYP3A4 K m = 62.77 μmol l –1 Fraction of unbound (f u ) 0.15 V max = 0.35 (pmol min 1 pmol protein –1 ) Blood/plasma 0.8 REF = 1 pKa 3.5 CYP2C19 K m = 33.85 μmol l –1 LogPo:w 2.76 V max = 1.48 (pmol/min/pmol protein) Absorption ADAM model REF = 8 P eff,man (10 –4 cm s –1 ) 7.01 UGT1A4 CL int = 0.012 (μl min –1 mg –1 protein) F uGut 1 CL R (L/h) 0.007 Formulation solution f a 0.99 predicted in Simcyp Concentration Assay:Article Title: Drug-Drug Interaction Potential of Mavacamten with Oral Contraceptives: Results from a Clinical Pharmacokinetic Study and a Physiologically Based Pharmacokinetic Model. Article Snippet: .. Simulations Using a other:Article Title: Toward improved predictions of pharmacokinetics of transported drugs in hepatic impairment: Insights from the extended clearance model Article Snippet: Indeed, whereas the AUCR HI of OATP/BET substrates pitavastatin, rosuvastatin, valsartan, and gadoxetic acid was relatively well‐predicted by |
